Mount Sinai Health System

NIH Common Fund’s High-Risk, High-Reward Research Program

The NIH Common Fund’s High-Risk, High-Reward Research program was created to support exceptionally creative scientists with highly innovative research ideas. Learn about the NIH Director’s Pioneer, New Innovator, Transformative Research, and Early Independence Awards, supporting high-impact research from scientists at all career stages.

Tuesday, January 23, 2018 at 1:00pm to 2:20pm

Davis Auditorium, Hess Center for Science and Medicine, Davis Auditorium 1470 Madison Avenue, New York, NY 10029

Event Type



Faculty, Postdocs, Staff, Students


Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital


Institute for Exposomic Research


research, NIH, High-Risk, High-Reward, Creative Scientists, Innovative Research, Transformative Research






Ravi Basavappa, Ph.D.

Dr. Basavappa received his Ph.D. in Biophysics from the University of Chicago for studies on the structure of tRNA. He then was a post-doctoral fellow at Harvard Medical School in virus crystallography. Prior to joining NIH, he was Associate Professor of Biochemistry and Biophysics at the University of Rochester School of Medicine, where he studied the structural aspects of mitotic control by targeted protein degradation. At Rochester, he also was a Research Scholar of the Leukemia and Lymphoma Society of America and Director of the Biophysics and Structural Biology Program. He joined NIH in 2004, first at NIGMS and then in the Office of the Director. His current responsibilities include serving as Program Leader for the Common Fund’s High-Risk, High-Reward Research Program.


Event Registration Required

This event requires registration.